All Stories

  1. Pharmacokinetic Evaluation of Tacrolimus in Chinese Adult Patients Receiving Voriconazole During the Early Stage Post-Lung Transplantation

    Article • September 2022, Research Square

    Zheng Jiao

  2. Parametric population pharmacokinetics of linezolid: A systematic review

    Article • British Journal of Clinical Pharmacology, May 2022, Wiley

    Zheng Jiao

  3. Model Informed Development of SIM0295 in Gout Patients with Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/pharmacodynamics Approach

    Article • April 2022, Research Square

    Zheng Jiao

  4. How to handle a delayed or missed dose of edoxaban in patients with non‐valvular atrial fibrillation? A model‐informed remedial strategy

    Article • British Journal of Clinical Pharmacology, April 2022, Wiley

    Zheng Jiao

  5. Population Pharmacokinetics of Oxcarbazepine: A Systematic Review

    Article • March 2022, Authorea, Inc.

    Zheng Jiao

  6. Population Pharmacokinetics of Linezolid: A Systematic Review

    Article • February 2022, Authorea, Inc.

    Zheng Jiao

  7. How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing

    Article • Expert Review of Clinical Pharmacology, July 2021, Taylor & Francis

    Zheng Jiao

  8. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co‐treated with tacrolimus: A population analysis

    Article • Journal of Clinical Pharmacy and Therapeutics, July 2021, Wiley

    Zheng Jiao

  9. Population pharmacokinetics of oxcarbazepine: a systematic review

    Article • Expert Review of Clinical Pharmacology, July 2021, Taylor & Francis

    Zheng Jiao

  10. Role of organic anion transporter 3 in the renal excretion of biapenem and potential drug-drug interactions

    Article • European Journal of Pharmaceutical Sciences, July 2021, Elsevier

    Zheng Jiao

  11. Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer

    Article • European Journal of Pharmaceutical Sciences, April 2021, Elsevier

    Zheng Jiao

  12. External evaluation of the predictive performance of seven population pharmacokinetic models for phenobarbital in neonates

    Article • British Journal of Clinical Pharmacology, March 2021, Wiley

    Zheng Jiao

  13. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing

    Article • International Journal of Antimicrobial Agents, March 2021, Elsevier

    Zheng Jiao

  14. Population Pharmacokinetics of Oxcarbazepine: A Systematic Review

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  15. Population Pharmacokinetics of Levetiracetam: A Systematic Review

    Article • Clinical Pharmacokinetics, January 2021, Springer Science + Business Media

    Zheng Jiao

  16. Investigating the interaction between nifedipine‐ and ritonavir‐containing antiviral regimens: a physiologically‐based pharmacokinetic/pharmacodynamic analysis

    Article • British Journal of Clinical Pharmacology, December 2020, Wiley

    Zheng Jiao

  17. Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions

    Article • British Journal of Clinical Pharmacology, October 2020, Wiley

    Zheng Jiao

  18. Remedial dosing recommendations for delayed or missed doses of valproic acid in patients with epilepsy based on Monte Carlo simulations

    Article • Epilepsy & Behavior, October 2020, Elsevier

    Zheng Jiao

  19. Incorporating nonlinear kinetics to improve predictive performance of population pharmacokinetic models for ciclosporin in adult renal transplant recipients: A comparison of modelling strategies

    Article • European Journal of Pharmaceutical Sciences, October 2020, Elsevier

    Zheng Jiao

  20. Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations

    Article • Clinical Pharmacokinetics, September 2020, Springer Science + Business Media

    Zheng Jiao

  21. External validation of the predictive performance of population pharmacokinetic models for phenobarbital in pediatric patients

    Article • September 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  22. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients

    Article • European Journal of Pharmaceutical Sciences, September 2020, Elsevier

    Zheng Jiao

  23. Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  24. Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  25. A Review of Population Pharmacokinetic Studies of Levetiracetam

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  26. Investigation on the interaction between nifedipine and ritonavir containing antivirus regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  27. Determination of vancomycin exposure target and individualized dosing recommendations for ICU neonates: model informed precision dosing

    Article • April 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  28. Population Pharmacokinetic Analysis of Tacrolimus in Adult Chinese Patients with Myasthenia Gravis: A Prospective Study

    Article • European Journal of Drug Metabolism and Pharmacokinetics, March 2020, Springer Science + Business Media

    Zheng Jiao

  29. Incorporating Nonlinear Kinetics to Improve the Predictive Performance of Population Pharmacokinetic Models for Ciclosporin in Adult Renal Transplant Recipients: A Comparison of Modelling Strategies

    Article • January 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  30. How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective

    Article • European Journal of Drug Metabolism and Pharmacokinetics, December 2019, Springer Science + Business Media

    Zheng Jiao

  31. Population Pharmacokinetic Study of Tacrolimus in Pediatric Patients with Primary Nephrotic Syndrome: A Comparison of Linear and Nonlinear Michaelis–Menten Pharmacokinetic Model

    Article • European Journal of Pharmaceutical Sciences, December 2019, Elsevier

    Zheng Jiao

  32. Remedial dosing recommendations for delayed or missed doses of lamotrigine in pediatric patients with epilepsy using Monte Carlo simulations

    Article • Epilepsy & Behavior, July 2019, Elsevier

    Zheng Jiao

  33. Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysis

    Article • Chinese Journal of Natural Medicines, March 2019, Elsevier

    Zheng Jiao

  34. Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemia

    Article • Pharmacogenomics, March 2019, Future Medicine

    Zheng Jiao

  35. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co‐administered with tacrolimus

    Article • British Journal of Clinical Pharmacology, February 2019, Wiley

    Zheng Jiao

  36. Population pharmacokinetics and dosing regimen optimisation of lopinavir in Chinese adults infected with HIV

    Article • Basic & Clinical Pharmacology & Toxicology, November 2018, Wiley

    Zheng Jiao

  37. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens

    Article • European Journal of Clinical Pharmacology, November 2018, Springer Science + Business Media

    Zheng Jiao

  38. Optimization and application of an HPLC method for quantification of inosine-5′-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients

    Article • Clinica Chimica Acta, October 2018, Elsevier

    Zheng Jiao

  39. Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus

    Article • Therapeutic Drug Monitoring, October 2018, Wolters Kluwer Health

    Zheng Jiao

  40. FKBP1A rs6041749 polymorphism is associated with allograft function in renal transplant patients

    Article • European Journal of Clinical Pharmacology, September 2018, Springer Science + Business Media

    Zheng Jiao

  41. FOXP3 rs3761549 polymorphism predicts long-term renal allograft function in patients receiving cyclosporine-based immunosuppressive regimen

    Article • Gene, February 2018, Elsevier

    Zheng Jiao

  42. External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients

    Article • British Journal of Clinical Pharmacology, November 2017, Wiley

    Zheng Jiao

  43. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling

    Article • Basic & Clinical Pharmacology & Toxicology, October 2017, Wiley

    Zheng Jiao

  44. NFATC1genotypes affect acute rejection and long-term graft function in cyclosporine-treated renal transplant recipients

    Article • Pharmacogenomics, March 2017, Future Medicine

    Zheng Jiao

  45. Chemical profiling of San-Huang decoction by UPLC–ESI-Q-TOF-MS

    Article • Journal of Pharmaceutical and Biomedical Analysis, November 2016, Elsevier

    Zheng Jiao

  46. FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients

    Article • European Journal of Clinical Pharmacology, October 2016, Springer Science + Business Media

    Zheng Jiao

  47. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients

    Article • British Journal of Clinical Pharmacology, February 2016, Wiley

    Zheng Jiao

  48. Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

    Article • Frontiers in Pharmacology, November 2015, Frontiers

    Zheng Jiao

  49. Effect of long-term coadministration of compound glycyrrhizin tablets on the pharmacokinetics of mycophenolic acid in rats

    Article • Xenobiotica, November 2015, Taylor & Francis

    Zheng Jiao

  50. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens

    Article • European Journal of Clinical Pharmacology, October 2015, Springer Science + Business Media

    Zheng Jiao

  51. Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy

    Article • Pharmacogenomics, August 2015, Future Medicine

    Zheng Jiao

  52. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy

    Article • Pharmacogenomics, March 2015, Future Medicine

    Zheng Jiao

  53. Population Pharmacokinetics of Valproic Acid in Adult Chinese Epileptic Patients and its Application in an Individualized Dosage Regimen

    Article • Therapeutic Drug Monitoring, February 2015, Wolters Kluwer Health

    Zheng Jiao

  54. A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation

    Article • Clinical Pharmacokinetics, November 2014, Springer Science + Business Media

    Zheng Jiao

  55. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil

    Article • European Journal of Clinical Pharmacology, October 2014, Springer Science + Business Media

    Zheng Jiao

  56. The effects of medication education and behavioral intervention on Chinese patients with epilepsy

    Article • Epilepsy & Behavior, August 2014, Elsevier

    Zheng Jiao

  57. Validation of Chinese version of the Morisky Medication Adherence Scale in patients with epilepsy

    Article • Seizure, April 2014, Elsevier

    Zheng Jiao

  58. Pharmacokinetic comparisons of berberine and palmatine in normal and metabolic syndrome rats

    Article • Journal of Ethnopharmacology, January 2014, Elsevier

    Zheng Jiao

  59. Citrate Pharmacokinetics in Critically Ill Patients with Acute Kidney Injury

    Article • PLoS ONE, June 2013, PLOS

    Zheng Jiao

  60. Self-reported adherence in patients with epilepsy who missed their medications and reasons for nonadherence in China

    Article • Epilepsy & Behavior, April 2013, Elsevier

    Zheng Jiao

  61. The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation

    Article • Acta Pharmacologica Sinica, October 2012, Springer Science + Business Media

    Zheng Jiao

  62. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients

    Article • Nephrology, April 2012, Wiley

    Zheng Jiao

  63. The Impact of Sulfonylureas on Tacrolimus Apparent Clearance Revealed by a Population Pharmacokinetics Analysis in Chinese Adult Liver-Transplant Patients

    Article • Therapeutic Drug Monitoring, April 2012, Wolters Kluwer Health

    Zheng Jiao

  64. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals

    Article • Clinica Chimica Acta, April 2012, Elsevier

    Zheng Jiao

  65. The Pharmacokinetics of Ropivacaine in Elderly Patients Undergoing Nerve Stimulator–Guided Thoracic Paravertebral Block

    Article • Journal of Cardiothoracic and Vascular Anesthesia, June 2011, Elsevier

    Zheng Jiao

  66. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis

    Article • Journal of Clinical Pharmacy and Therapeutics, October 2010, Wiley

    Zheng Jiao

  67. Simultaneous determination of procaine, lidocaine, ropivacaine, tetracaine and bupivacaine in human plasma by high-performance liquid chromatography

    Article • Journal of Chromatography B, May 2010, Elsevier

    Zheng Jiao

  68. Simple and Sensitive Determination of Metformin in Human Plasma Using an Ion-Pair LC Method

    Article • Chromatographia, October 2009, Springer Science + Business Media

    Zheng Jiao

  69. Population pharmacokinetics of sirolimus inde novoChinese adult renal transplant patients

    Article • British Journal of Clinical Pharmacology, July 2009, Wiley

    Zheng Jiao

  70. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

    Article • European Journal of Clinical Pharmacology, July 2008, Springer Science + Business Media

    Zheng Jiao

  71. Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9

    Article • British Journal of Clinical Pharmacology, June 2008, Wiley

    Zheng Jiao

  72. Simultaneous determination of aciclovir, ganciclovir, and penciclovir in human plasma by high-performance liquid chromatography with fluorescence detection

    Article • Journal of Chromatography B, May 2008, Elsevier

    Zheng Jiao

  73. Isocratic Reversed-Phase HPLC for Simultaneous Separation and Determination of Seven Antiepileptic Drugs and Two of their Active Metabolites in Human Plasma

    Article • Chromatographia, January 2007, Springer Science + Business Media

    Zheng Jiao

  74. Quantification of Teicoplanin in Human Plasma by Liquid Chromatography with Ultraviolet Detection

    Article • Chromatographia, November 2006, Springer Science + Business Media

    Zheng Jiao

  75. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies

    Article • European Journal of Clinical Pharmacology, November 2006, Springer Science + Business Media

    Zheng Jiao

  76. Simultaneous determination of mycophenolic acid and valproic acid based on derivatization by high-performance liquid chromatography with fluorescence detection

    Article • Biomedical Chromatography, January 2006, Wiley

    Zheng Jiao

  77. Errata

    Article • Chromatographia, November 2005, Springer Science + Business Media

    Zheng Jiao

  78. Simple High-Performance Liquid Chromatographic Assay, with Post-Column Derivatization, for Simultaneous Determination of Mycophenolic Acid and its Glucuronide Metabolite in Human Plasma and Urine

    Article • Chromatographia, October 2005, Springer Science + Business Media

    Zheng Jiao

  79. Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection

    Article • Journal of Chromatography B, March 2005, Elsevier

    Zheng Jiao

  80. The Validation of an LC-MS Method for the Determination of Risperidone and its Active Metabolite 9-Hydroxyrisperidone in Human Plasma

    Article • Chromatographia, March 2005, Springer Science + Business Media

    Zheng Jiao

  81. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data

    Article • Journal of Clinical Pharmacy and Therapeutics, June 2004, Wiley

    Zheng Jiao

  82. Population Pharmacokinetics of Carbamazepine in Chinese Epilepsy Patients

    Article • Therapeutic Drug Monitoring, June 2003, Wolters Kluwer Health

    Zheng Jiao